Location History:
- Los Angeles, CA (US) (2009)
- Alhambra, CA (US) (2006 - 2011)
Company Filing History:
Years Active: 2006-2011
Title: Jingsong Xu: Innovator in Angiogenesis Research
Introduction
Jingsong Xu, an accomplished inventor based in Alhambra, CA, has made significant contributions to the field of angiogenesis research. With a total of four patents to his name, Xu's work focuses on innovative methods for inhibiting angiogenesis, a process critical to tumor growth and metastasis. His latest patents showcase a blend of scientific expertise and practical applications in biomedical research.
Latest Patents
Xu's most recent inventions include methods for inhibiting angiogenesis by utilizing antagonists that specifically bind to proteolyzed or denatured collagen, without affecting the native triple helical forms. These antagonists target various types of denatured collagens, including type-I, type-II, type-III, type-IV, and type-V. The methods devised by Xu not only provide therapeutic treatments for tumor growth and metastasis but also serve as diagnostic markers of angiogenesis in both normal and diseased tissues, both in vivo and ex vivo. Among the notable antagonists highlighted in these patents are monoclonal antibodies named HUI77, HUIV26, and XL313.
Career Highlights
Xu is affiliated with the University of Southern California, where his research has gained recognition for its potential impact on cancer treatment and diagnosis. Throughout his career, he has been dedicated to advancing the understanding of angiogenesis and its implications in various diseases. His inventive contributions have earned him a notable reputation in the scientific community.
Collaborations
In his pursuit of innovation, Xu has collaborated with distinguished colleagues such as Peter C. Brooks and Eric Petitclerc. These collaborations enhance the interdisciplinary approach to his research, fostering advancements in the methods and applications related to angiogenesis and tumor treatment strategies.
Conclusion
Jingsong Xu stands out as a prominent inventor in the realm of angiogenesis research. His innovative patents and collaborative efforts hold great promise for therapeutic and diagnostic advancements in the medical field. As his work continues to evolve, it underscores the importance of research and innovation in combating diseases such as cancer.